Association of hypertension with symptoms of benign prostatic hyperplasia.
about
Risk of acute myocardial infarction after transurethral resection of prostate in elderlyAngiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta1 in prostate tissue of spontaneously hypertensive ratsAssociation between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study.The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.Medical attendance for lower urinary tract symptoms is associated with subsequent increased risk of outpatient visits and hospitalizations based on a nationwide population-based database.Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensiCan metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis.Relationship between Metabolic Syndrome and Lower Urinary Tract Symptoms: Hallym Aging Study.Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular system.Mortality in men admitted to hospital with acute urinary retention: database analysis.Roles of urology as assessed by an analysis of inpatients referred to urology.Metabolic syndrome is predictive of lower urinary tract symptom improvement after holmium laser enucleation of the prostate for benign prostatic obstruction.Correlation between risk factors for vascular disease and the American Urological Association Symptom Score.Men's lower urinary tract symptoms are also mental and physical sufferings for their spousesHyperglycemia, hyperinsulinemia, insulin resistance, and the risk of BPH/LUTS severity and progression over time in community dwelling black men: the Flint Men's Health Study.Causes and mechanisms of nondipping hypertension.Voiding dysfunction in men: pathophysiology and risk factors.Are lower urinary tract symptoms in men associated with cardiovascular diseases in a primary care population: a registry study.Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study.Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasStandard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: analysis of 100 cases from a high-volume urologic centerAssociation of a Missense ALDH2 Single Nucleotide Polymorphism (Glu504Lys) With Benign Prostate Hyperplasia in a Korean PopulationMetabolic syndrome and urologic diseases.Are polymorphisms of the β(3)-adrenoceptor gene associated with an altered bladder function?Relationship between endothelial dysfunction and nocturia with benign prostatic hyperplasia.Does concomitant diabetes affect treatment responses in overactive bladder patients?Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia.Lower urinary tract symptoms in patients with liver cirrhosis.One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms.Characterization of the urinary bladder dysfunction in renovascular hypertensive rats.Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α/α-Adrenergic Receptor Antagonist with Potential Uroselective Profile
P2860
Q26859700-EA8C94E8-ECD8-4368-8523-DC26C4105559Q28571464-727B0D94-96EA-4527-BE10-D50F08F6AAAAQ34009467-D6CF46DF-5F86-4895-A402-6D8F43D78C7CQ34590302-F19062B4-230A-4AA9-82FF-80B9A32CA2B5Q34614481-E1422554-85D6-4AB3-AD9F-133E452265B7Q35001406-213F3E7B-E75C-4E98-86C4-BA5BC4B81516Q35228167-F8350C96-FFF5-4A9C-A624-E737CD69121FQ35630890-3FB8ADB1-2751-476F-9B42-089B0E15C637Q35823776-2F93574C-0579-4A74-8EBA-EF918FDE244AQ36116539-DA527199-11AD-430B-81AA-10FFCC2C0150Q36248512-6ECE19AC-C228-4A3D-8118-EC646F4211ECQ36284747-3638184B-89F7-473A-A922-C8209DF0B5E7Q36329234-789F4F34-1FAB-4BB2-970C-ABBCC4ADAC10Q36709646-0F020FEF-8075-4CF7-9734-A9C5AF0C920FQ37166618-BFCB05B5-D2BC-498E-8ABC-D6598B1FB8D4Q37209797-17C236BE-2EF8-48AC-A7F5-0288807E01FBQ37293950-1FA5D135-57C6-4904-88FB-DDFAB4402313Q37323306-1AD379AF-83C9-4B4E-B78D-333C9ADD3032Q37502247-D27BD6E9-44A7-4405-84D9-4466D21EED70Q38220350-C620C56B-DDBD-4083-A441-0C5BD5CEBDDBQ39095837-47419734-6A1E-4814-A9DA-57091C406A25Q39123658-4745B291-7AA5-4382-ABBD-7EB4F35D070AQ39195242-3240CE29-318E-41E6-812E-B6C7DFD275BCQ40615541-D183D17E-209D-474F-AB55-3D69E723AD9CQ41821634-465ECAB1-0196-427E-802D-A83A0F646066Q41878606-13D0A6AD-14E1-419F-AA64-FF3919970E33Q42757693-F5504394-4032-49F4-808B-001931B38461Q44874339-4C1F2307-28CD-48E4-8252-1E1D4BF9D1FFQ45309524-8F7E8EEF-3C7A-4A93-B64F-D407B45D133BQ46189177-2F2B3FF9-62D7-4E8B-88D7-9F1622F0E0CAQ47614558-3954638E-3804-4744-B710-19D9C9946CCAQ48457200-61FD2D6B-51BC-46D8-A500-DF0B782B6F48Q53090397-C8F48354-B25E-4C18-B6BE-68DD4D4394E7Q53108829-3EFFF726-0841-486A-84E2-3338B5C0DFA1Q54583146-77E4D352-4E13-48D2-98FF-45D0950D3BB9Q58691700-E170BBAA-0D2B-4966-9494-4ADDDAB1192A
P2860
Association of hypertension with symptoms of benign prostatic hyperplasia.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Association of hypertension with symptoms of benign prostatic hyperplasia.
@ast
Association of hypertension with symptoms of benign prostatic hyperplasia.
@en
Association of hypertension with symptoms of benign prostatic hyperplasia.
@nl
type
label
Association of hypertension with symptoms of benign prostatic hyperplasia.
@ast
Association of hypertension with symptoms of benign prostatic hyperplasia.
@en
Association of hypertension with symptoms of benign prostatic hyperplasia.
@nl
prefLabel
Association of hypertension with symptoms of benign prostatic hyperplasia.
@ast
Association of hypertension with symptoms of benign prostatic hyperplasia.
@en
Association of hypertension with symptoms of benign prostatic hyperplasia.
@nl
P2093
P1476
Association of hypertension with symptoms of benign prostatic hyperplasia.
@en
P2093
Helmut Schumacher
Ludwig Mehlburger
Mark Goepel
Uwe Heemann
P304
P356
10.1097/01.JU.0000139995.85780.D8
P407
P433
P577
2004-10-01T00:00:00Z